Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors (Q79760267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

main subject

adrenocortical carcinoma

1 reference

inferred from title

United States of America

1 reference

7

Cord Sturgeon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

Electron Kebebew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Karl Y Bilimoria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Wen T Shen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Dina Elaraj

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

David J Bentrem

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

David J Winchester

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

3130-3136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

Management of patients with adrenal cancer: recommendations of an international consensus conference.

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Outcomes of adrenal cortical carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Adrenocortical carcinoma: surgical progress or status quo?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Adrenal cortical carcinoma--review of current knowledge and treatment practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Clinical review: Adrenocortical carcinoma: clinical update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Adjuvant mitotane treatment for adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Emerging treatment strategies for adrenocortical carcinoma: a new hope.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23886

7 January 2021

Identifiers

DOI

10.1002/CNCR.23886

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18973179%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference